Preview: India's third largest pharmaceutical company, Cipla, is scheduled to deliver its October-December quarterly earnings ...

New Delhi: In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central ...

There has been a lot of buzz over the regulation of dietary or nutritional supplements. But do you even need them?

Bonus Oct 18, 1999 Nov 05, 1999 Oct 07, 1999 Bonus Ratio: 2 share(s) for every 1 shares held Rights Feb 03, 1995 Mar 02, 1995 May 03, 1995 Rights ratio: 4 share for every 50 held at a price of Rs ...

India's drug regulator identifies 135 drugs as 'not of standard quality' in December, including popular medications.

Indian pharma companies like Dr Reddys, Zydus, Cipla, and Sun can sustain low double-digit EPS growth over the medium term.

The US healthcare system under Trump 2.0 are likely to benefit Indian players, except for the push for increased US drug ...

Cipla said that the United States Food and Drugs Administration (US FDA) has issued one observation in Form 483 to the manufacturing facility of its wholly-owned subsidiary Medispray Laboratories.

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the ...

Stocks like L&T Finance, Sunteck Realty, Jammu and Kashmir Bank, Prakash Industries, Bank of Baroda, Torrent Power, Landmark ...

Cipla on Monday (January 20) announced that the United States Food and Drug Administration conducted an inspection of its ...